Dr. Balazs  Sarkadi
My Social Links

Dr. Balazs Sarkadi

Research Professor
Hungarian Academy of Sciences, Hungary


Highest Degree
PostDoc. in Cell Biology from University of Toronto, Canada

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Tissue Biomechanics
62%
Membrane Protein
90%
Pharmacology
75%
Stem Cell
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Klawitter, S., N.V. Fuchs, K.R. Upton, M. Munoz-Lopez and R. Shukla et al., 2016. Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells. Nat. commun., Vol. 7. 10.1038/ncomms10286.
    CrossRef  |  Direct Link  |  
  2. Apáti, A., T. Berecz and B. Sarkadi, 2016. Calcium signaling in human pluripotent stem cells. Cell calcium, 59: 117-123.
    CrossRef  |  Direct Link  |  
  3. Apati, A., K. Szebenyi, Z. Erdei, G. Varady, T.I. Orban and B. Sarkadi, 2016. The importance of drug transporters in human pluripotent stem cells and in early tissue differentiation. Expert Opin. Drug Metab. Toxicol., 12: 77-92.
    CrossRef  |  Direct Link  |  
  4. Szebenyi, K., A. Furedi, O. Kolacsek, E. Pergel and Z. Bosze et al., 2015. Generation of a homozygous transgenic rat strain stably expressing a calcium sensor protein for direct examination of calcium signaling. Sci. Rep., Vol. 5. 10.1038/srep12645.
    CrossRef  |  Direct Link  |  
  5. Pomozi, V., O.L. Saux, C. Brampton, A. Apana and A. Ilias et al., 2013. ABCC6 is a basolateral plasma membrane protein. Circulation Res., 112: 148-151.
    CrossRef  |  Direct Link  |  
  6. Brozik, A., C. Hegedus, Z. Erdei, T. Hegedus, C. Ozvegy-Laczka, G. Szakacs and B. Sarkadi, 2011. Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: Substrates, chemosensitizers or inducers of acquired multidrug resistance. Expert Opinion Drug Metab. Toxicol., 7: 623-642.
    CrossRef  |  Direct Link  |  
  7. Schneider, C.K., B. Sarkadi and P. Celis, 2010. Challenges with advanced therapy medicinal products and how to meet them. Nat. Rev. Drug Discov, 9: 195-201.
    CrossRef  |  Direct Link  |  
  8. Sarkadi, B. and G. Szakacs, 2010. Understanding transport through pharmacological barriers-are we there yet. Nat. Rev. Drug Discovery, 9: 897-898.
  9. Orban, T.I., A. Apati, A. Nemeth, N. Varga and V. Krizsik et al., 2009. Applying a “Double‐Feature” promoter to identify cardiomyocytes differentiated from human embryonic stem cells following transposon‐based gene delivery. Stem cells, 27: 1077-1087.
    CrossRef  |  Direct Link  |  
  10. Szakacs, G., A. Varadi, C. Ozvegy-Laczka and B. Sarkadi, 2008. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Dscovery Today, 13: 379-393.
    CrossRef  |  Direct Link  |  
  11. Sarkadi, B., L. Homolya, G. Szakacs and A. Varadi, 2006. Human multidrug resistance ABCB and ABCG transporters: Participation in a chemoimmunity defense system. Physiol. Rev., 86: 1179-1236.
    CrossRef  |  Direct Link  |  
  12. Elkind, N.B., Z. Szentpetery, A. Apati, C. Ozvegy-Laczka and G. Varady et al., 2005. Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib). Cancer Res., 65: 1770-1777.
    CrossRef  |  Direct Link  |